Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Nanjing Zhengxiang Pharmaceuticals divulges DHODH inhibitors

Feb. 9, 2022

Discovery of novel monoclonal antibodies against emerging SARS-CoV-2 variants of concern

Feb. 9, 2022

In vitro data show proof of concept for Theralase SARS-CoV-2 vaccine

Feb. 8, 2022

Antibody DH-1047 shows protection against SARS-related strains and SARS-CoV-2 variants

Feb. 8, 2022

Preclinical data presented for ch128.1/IgG1 in NWM hemorrhagic fever

Feb. 8, 2022

Ascletis reports preclinical data on ASC-10 and ASC-10-A against SARS-CoV-2 variants

Feb. 7, 2022

Enanta Pharmaceuticals presents compounds for influenza, RSV infections

Feb. 4, 2022

Epigenetic-mediated immune mechanisms identified in TB

Feb. 3, 2022

Discovery of novel MBL inhibitors as promising beta-lactam antibiotics

Feb. 3, 2022

ReViral describes new compounds for respiratory syncytial virus infections

Feb. 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...